Sulaiman Al Habib Group shareholders authorize board to pay interim dividend for FY2020

Dr Sulaiman Al Habib Medical Group’s shareholders approved authorizing the board to pay interim dividend for the fiscal year 2020 on a quarterly or semi-annual basis, during the company's extraordinary general meeting held on May 10.

The company said in a bourse statement that the shareholders approved the board’s recommendation to appoint Dr. Nabeel bin Muhammad bin Omar AlAmudi (independent member) as a member in the board of directors from the date of his appointment on March 30, 2020 until the end of the current session on Dec.9, 2021.

He will succeed the previous non-executive member, Samer Saeed Muhammad Jundi, the statement added.

Shareholders also approved the appointment of Ernst & Young & Associates Chartered Accountants as external auditor to review and audit financial statements for Q2, Q3, Q4 and FY 2020 and Q1 2021.

Dr Sulaiman Al Habib Medical Group was listed and started trading on the Saudi Stock Exchange (Tadawul) on March 17.